Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
4951
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.56M | ﹤0.01% |
1,506,155
-242,336
| -14% | -$416K |
|
4952
Vanguard US Quality Factor ETF
VFQY
$506M
| $2.56M | ﹤0.01% |
+26,106
| New | +$2.79M |
|
4953
CALL
GoodRx Holdings
GDRX
$1.27B
| $2.56M | ﹤0.01% |
431,600
-26,400
| -6% | -$294K |
|
4954
CALL
Natural Resource Partners
NRP
$1.39B
| $2.55M | ﹤0.01% |
68,600
-1,700
| -2% | -$77.1K |
|
|
AJRD
4955
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $2.55M | ﹤0.01% |
62,900
-41,900
| -40% | -$1.69M |
|
4956
PUT
Tanger
SKT
$4.42B
| $2.55M | ﹤0.01% |
179,500
-23,100
| -11% | -$383K |
|
4957
Airbnb
ABNB
$110B
| $2.55M | ﹤0.01% |
28,630
-916,109
| -97% | -$119M |
|
4958
Vanguard Morningstar Growth ETF
VUG
$230B
| $2.55M | ﹤0.01% |
68,628
-106,092
| -61% | -$4.36M |
|
4959
CALL
Direxion Daily Technology Bear 3x ETF
TECS
$59.6M
| $2.54M | ﹤0.01% |
509
+23
| +5% | +$98.9K |
|
|
ISEE
4960
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.54M | ﹤0.01% |
264,600
+158,200
| +149% | +$1.99M |
|
4961
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $2.54M | ﹤0.01% |
114,640
+6,161
| +6% | +$143K |
|
4962
CALL
United States Copper Index Fund
CPER
$774M
| $2.54M | ﹤0.01% |
114,400
+38,000
| +50% | +$997K |
|
4963
PUT
Teucrium Wheat Fund
WEAT
$305M
| $2.54M | ﹤0.01% |
56,220
-7,980
| -12% | -$431K |
|
4964
Sportsman's Warehouse
SPWH
$46.4M
| $2.54M | ﹤0.01% |
264,756
-250,136
| -49% | -$2.47M |
|
4965
AMERISAFE
AMSF
$513M
| $2.54M | ﹤0.01% |
48,795
+30,453
| +166% | +$1.48M |
|
|
BPT
4966
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $2.54M | ﹤0.01% |
124,000
-7,700
| -6% | -$138K |
|
4967
The Greenbrier Companies
GBX
$1.41B
| $2.54M | ﹤0.01% |
70,517
+33,318
| +90% | +$1.39M |
|
4968
CALL
Leslie's
LESL
$6.04M
| $2.54M | ﹤0.01% |
8,360
+2,910
| +53% | +$1.09M |
|
|
RETA
4969
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.54M | ﹤0.01% |
83,500
-128,400
| -61% | -$3.83M |
|
4970
PUT
AllianceBernstein
AB
$3.41B
| $2.54M | ﹤0.01% |
61,000
-27,400
| -31% | -$1.15M |
|
4971
PUT
Cooper Companies
COO
$14.9B
| $2.54M | ﹤0.01% |
32,400
-76,800
| -70% | -$6.8M |
|
4972
CALL
Patterson-UTI
PTEN
$4.34B
| $2.54M | ﹤0.01% |
160,900
+99,400
| +162% | +$1.67M |
|
4973
Innovator US Equity Accelerated Plus ETF July
XTJL
$16.9M
| $2.54M | ﹤0.01% |
113,478
+12,300
| +12% | +$305K |
|
4974
PUT
STAAR Surgical
STAA
$1.31B
| $2.53M | ﹤0.01% |
35,700
-3,400
| -9% | -$219K |
|
4975
Toll Brothers
TOL
$13.9B
| $2.53M | ﹤0.01% |
56,787
-9,765
| -15% | -$457K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.